H Grant Skaggs Jr

Array ( [id] => 7288068 [patent_doc_number] => 20040147468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Immunostimulatory nucleic acid molecules' [patent_app_type] => new [patent_app_number] => 10/679710 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 21850 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147468.pdf [firstpage_image] =>[orig_patent_app_number] => 10679710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7210619 [patent_doc_number] => 20050053916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Diagnostic for long term response of HBV carrier to 3TC therapy' [patent_app_type] => utility [patent_app_number] => 10/677920 [patent_app_country] => US [patent_app_date] => 2003-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 28010 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053916.pdf [firstpage_image] =>[orig_patent_app_number] => 10677920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11813821 [patent_doc_number] => 09717754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-01 [patent_title] => 'Glucocerebroside treatment of disease' [patent_app_type] => utility [patent_app_number] => 10/675980 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 7149 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10675980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291383 [patent_doc_number] => 20040110795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Use of iminosugar derivatives to inhibit ion channel activity' [patent_app_type] => new [patent_app_number] => 10/669175 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10267 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110795.pdf [firstpage_image] =>[orig_patent_app_number] => 10669175 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7379049 [patent_doc_number] => 20040028698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Vaccine' [patent_app_type] => new [patent_app_number] => 10/381486 [patent_app_country] => US [patent_app_date] => 2003-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11533 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028698.pdf [firstpage_image] =>[orig_patent_app_number] => 10381486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7405727 [patent_doc_number] => 20040105872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides' [patent_app_type] => new [patent_app_number] => 10/666022 [patent_app_country] => US [patent_app_date] => 2003-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14258 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20040105872.pdf [firstpage_image] =>[orig_patent_app_number] => 10666022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211499 [patent_doc_number] => 20050054003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Prion clearance using particulate metal oxides' [patent_app_type] => utility [patent_app_number] => 10/659789 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6208 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054003.pdf [firstpage_image] =>[orig_patent_app_number] => 10659789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020166 [patent_doc_number] => 08530151 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells' [patent_app_type] => utility [patent_app_number] => 10/654298 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 17056 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 337 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10654298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776303 [patent_doc_number] => 20060104943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Vaccine comprising il-13 and an adjuvant' [patent_app_type] => utility [patent_app_number] => 10/526151 [patent_app_country] => US [patent_app_date] => 2003-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11244 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104943.pdf [firstpage_image] =>[orig_patent_app_number] => 10526151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7211494 [patent_doc_number] => 20050054002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Reagent for ante-mortem screening of NCTA' [patent_app_type] => utility [patent_app_number] => 10/651020 [patent_app_country] => US [patent_app_date] => 2003-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1263 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054002.pdf [firstpage_image] =>[orig_patent_app_number] => 10651020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7441910 [patent_doc_number] => 20040185555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-23 [patent_title] => 'Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby' [patent_app_type] => new [patent_app_number] => 10/645883 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 97 [patent_figures_cnt] => 97 [patent_no_of_words] => 11809 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20040185555.pdf [firstpage_image] =>[orig_patent_app_number] => 10645883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7408278 [patent_doc_number] => 20040106194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Methods for propagating adenovirus and virus produced thereby' [patent_app_type] => new [patent_app_number] => 10/645794 [patent_app_country] => US [patent_app_date] => 2003-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 18712 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10645794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4514441 [patent_doc_number] => 07932043 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'Use of monoclonal antibodies to distinguish protein conformational isoforms' [patent_app_type] => utility [patent_app_number] => 10/490977 [patent_app_country] => US [patent_app_date] => 2003-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11377 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/932/07932043.pdf [firstpage_image] =>[orig_patent_app_number] => 10490977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5215645 [patent_doc_number] => 20070104726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Multimeric complexes of antigens and adjuvants' [patent_app_type] => utility [patent_app_number] => 10/523593 [patent_app_country] => US [patent_app_date] => 2003-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12119 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20070104726.pdf [firstpage_image] =>[orig_patent_app_number] => 10523593 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7034403 [patent_doc_number] => 20050032913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Decontamination of prion-contaminated surfaces with phenols' [patent_app_type] => utility [patent_app_number] => 10/637149 [patent_app_country] => US [patent_app_date] => 2003-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5393 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20050032913.pdf [firstpage_image] =>[orig_patent_app_number] => 10637149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5842991 [patent_doc_number] => 20060121448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Method for inducing complete hepatitis c virus (hcv) replication in vitro' [patent_app_type] => utility [patent_app_number] => 10/523602 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 50 [patent_no_of_words] => 17470 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121448.pdf [firstpage_image] =>[orig_patent_app_number] => 10523602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 326644 [patent_doc_number] => 07514415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-07 [patent_title] => 'Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides' [patent_app_type] => utility [patent_app_number] => 10/523273 [patent_app_country] => US [patent_app_date] => 2003-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 17125 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/514/07514415.pdf [firstpage_image] =>[orig_patent_app_number] => 10523273 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7423025 [patent_doc_number] => 20040265300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)' [patent_app_type] => new [patent_app_number] => 10/627649 [patent_app_country] => US [patent_app_date] => 2003-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 15439 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265300.pdf [firstpage_image] =>[orig_patent_app_number] => 10627649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468611 [patent_doc_number] => 20040096451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies' [patent_app_type] => new [patent_app_number] => 10/628088 [patent_app_country] => US [patent_app_date] => 2003-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 76753 [patent_no_of_claims] => 84 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096451.pdf [firstpage_image] =>[orig_patent_app_number] => 10628088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408324 [patent_doc_number] => 07285642 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-23 [patent_title] => 'Composition and method for modulating dendritic cell-T cell interaction' [patent_app_type] => utility [patent_app_number] => 10/625204 [patent_app_country] => US [patent_app_date] => 2003-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 13858 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285642.pdf [firstpage_image] =>[orig_patent_app_number] => 10625204 [rel_patent_id] =>[rel_patent_doc_number] =>)